News
PPBT
2.540
+2.83%
0.070
Weekly Report: what happened at PPBT last week (1111-1115)?
Weekly Report · 4d ago
Purple Biotech Price Target Maintained With a $33.00/Share by HC Wainwright & Co.
Dow Jones · 6d ago
HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target
Benzinga · 6d ago
Promising Interim Results Propel Purple Biotech’s Buy Rating Amid Phase 2 Success and Strategic Advancements
TipRanks · 6d ago
Purple Biotech Ltd. Reports Progress in Phase 2 CM24 Pancreatic Cancer Trial and Biomarker Developments, Financial Results for Q3 2024
Barchart · 6d ago
Purple Biotech’s Promising Trials and Financial Update
TipRanks · 6d ago
Purple Biotech GAAP EPS of -$0.39
Seeking Alpha · 11/15 12:10
Purple Biotech reports Q3 EPS (39c) vs ($4.63) last year
TipRanks · 11/15 12:05
PURPLE BIOTECH LTD: QTRLY LOSS PER ADS $4.57
Reuters · 11/15 12:00
Purple Biotech Reports Third Quarter 2024 Financial Results
Barchart · 11/15 06:00
Weekly Report: what happened at PPBT last week (1104-1108)?
Weekly Report · 11/11 09:44
Purple Biotech Unveils Promising Biomarker for Cancer Therapy
TipRanks · 11/04 13:13
Purple Biotech identifies potential new serum biomarker for CM24
TipRanks · 11/04 12:56
PURPLE BIOTECH LTD - PHASE 2 STUDY OF CM24 IN PANCREATIC CANCER EXPECTED Q4 2024 RESULTS
Reuters · 11/04 12:50
Weekly Report: what happened at PPBT last week (1028-1101)?
Weekly Report · 11/04 09:44
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
Barchart · 11/04 06:50
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 11/01 20:36
Weekly Report: what happened at PPBT last week (1021-1025)?
Weekly Report · 10/28 09:41
Purple Biotech Advances with CAPTN-3 Cancer Platform
TipRanks · 10/25 11:53
Purple Biotech Presents New Data Regarding Its Tri-Specific Antibody Platform, CAPTN-3
Benzinga · 10/25 11:23
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.